Delivery Order SPE2DE24D0013-SPE2D626F001D

The Defense Logistics Agency Medical Supply Chain awarded a $9,868.32 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, for respiratory diagnostic testing supplies related to COVID-19, influenza, and respiratory syncytial virus detection. The delivery order, which carries an ultimate completion date of November 13, 2025, represents a near-term procurement of molecular diagnostic reagents and test kits utilizing Cepheid's GeneXpert diagnostic platform. No set-aside designation was applied to this award. The contract is performed at Cepheid's headquarters location in Sunnyvale, California.

Cepheid is a established federal supplier of advanced molecular diagnostic systems and reagents, with extensive prior contracting relationships across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds significant Indefinite Delivery Contracts with the VA totaling over $39.5 million through 2030, which serve as the primary contracting mechanism for ongoing procurement of diagnostic testing solutions. This delivery order falls within the scope of Cepheid's core competencies in providing rapid molecular diagnostic testing capabilities and reflects the Defense Logistics Agency's continued reliance on the company as a supplier of critical diagnostic supplies to support federal healthcare operations.